Logo image of 1BRKR.MI

BRUKER CORP (1BRKR.MI) Stock Fundamental Analysis

BIT:1BRKR - Euronext Milan - US1167941087 - Common Stock - Currency: EUR

34.61  +34.61 (+Infinity%)

Fundamental Rating

3

Overall 1BRKR gets a fundamental rating of 3 out of 10. We evaluated 1BRKR against 22 industry peers in the Life Sciences Tools & Services industry. 1BRKR has a bad profitability rating. Also its financial health evaluation is rather negative. 1BRKR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1BRKR was profitable.
1BRKR had a positive operating cash flow in the past year.
1BRKR had positive earnings in each of the past 5 years.
In the past 5 years 1BRKR always reported a positive cash flow from operatings.
1BRKR.MI Yearly Net Income VS EBIT VS OCF VS FCF1BRKR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

1BRKR has a Return On Assets of 1.34%. This is in the lower half of the industry: 1BRKR underperforms 63.64% of its industry peers.
1BRKR has a Return On Equity of 4.38%. This is in the lower half of the industry: 1BRKR underperforms 63.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.54%, 1BRKR is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1BRKR is below the industry average of 12.40%.
Industry RankSector Rank
ROA 1.34%
ROE 4.38%
ROIC 5.54%
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1BRKR.MI Yearly ROA, ROE, ROIC1BRKR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

1BRKR has a Profit Margin of 2.31%. This is in the lower half of the industry: 1BRKR underperforms 77.27% of its industry peers.
1BRKR's Profit Margin has declined in the last couple of years.
1BRKR's Operating Margin of 10.99% is on the low side compared to the rest of the industry. 1BRKR is outperformed by 68.18% of its industry peers.
1BRKR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 49.28%, 1BRKR belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
1BRKR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.99%
PM (TTM) 2.31%
GM 49.28%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
1BRKR.MI Yearly Profit, Operating, Gross Margins1BRKR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1BRKR is still creating some value.
Compared to 1 year ago, 1BRKR has more shares outstanding
1BRKR has less shares outstanding than it did 5 years ago.
1BRKR has a worse debt/assets ratio than last year.
1BRKR.MI Yearly Shares Outstanding1BRKR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1BRKR.MI Yearly Total Debt VS Total Assets1BRKR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

1BRKR has an Altman-Z score of 2.39. This is not the best score and indicates that 1BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.39, 1BRKR perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
The Debt to FCF ratio of 1BRKR is 12.11, which is on the high side as it means it would take 1BRKR, 12.11 years of fcf income to pay off all of its debts.
1BRKR has a worse Debt to FCF ratio (12.11) than 68.18% of its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that 1BRKR has dependencies on debt financing.
The Debt to Equity ratio of 1BRKR (1.14) is worse than 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 12.11
Altman-Z 2.39
ROIC/WACC0.73
WACC7.6%
1BRKR.MI Yearly LT Debt VS Equity VS FCF1BRKR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.57 indicates that 1BRKR should not have too much problems paying its short term obligations.
1BRKR's Current ratio of 1.57 is in line compared to the rest of the industry. 1BRKR outperforms 45.45% of its industry peers.
A Quick Ratio of 0.72 indicates that 1BRKR may have some problems paying its short term obligations.
The Quick ratio of 1BRKR (0.72) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.72
1BRKR.MI Yearly Current Assets VS Current Liabilites1BRKR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The earnings per share for 1BRKR have decreased by -8.56% in the last year.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
The Revenue has grown by 14.84% in the past year. This is quite good.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.56%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-11.32%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%11.04%

3.2 Future

Based on estimates for the next years, 1BRKR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.88% on average per year.
The Revenue is expected to grow by 5.08% on average over the next years.
EPS Next Y3.14%
EPS Next 2Y7.87%
EPS Next 3Y10.41%
EPS Next 5Y10.88%
Revenue Next Year4.82%
Revenue Next 2Y4.35%
Revenue Next 3Y4.78%
Revenue Next 5Y5.08%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1BRKR.MI Yearly Revenue VS Estimates1BRKR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
1BRKR.MI Yearly EPS VS Estimates1BRKR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.80 indicates a correct valuation of 1BRKR.
90.91% of the companies in the same industry are more expensive than 1BRKR, based on the Price/Earnings ratio.
1BRKR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.08, which indicates a correct valuation of 1BRKR.
90.91% of the companies in the same industry are more expensive than 1BRKR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.21. 1BRKR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.8
Fwd PE 14.08
1BRKR.MI Price Earnings VS Forward Price Earnings1BRKR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

1BRKR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1BRKR is cheaper than 72.73% of the companies in the same industry.
63.64% of the companies in the same industry are cheaper than 1BRKR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.25
EV/EBITDA 13.68
1BRKR.MI Per share data1BRKR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1BRKR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.36
PEG (5Y)1.88
EPS Next 2Y7.87%
EPS Next 3Y10.41%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.52%, 1BRKR is not a good candidate for dividend investing.
1BRKR's Dividend Yield is a higher than the industry average which is at 0.69.
Compared to an average S&P500 Dividend Yield of 2.39, 1BRKR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

The dividend of 1BRKR has a limited annual growth rate of 4.81%.
Dividend Growth(5Y)4.81%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1BRKR pays out 38.44% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1BRKR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.44%
EPS Next 2Y7.87%
EPS Next 3Y10.41%
1BRKR.MI Yearly Income VS Free CF VS Dividend1BRKR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1BRKR.MI Dividend Payout.1BRKR.MI Dividend Payout, showing the Payout Ratio.1BRKR.MI Dividend Payout.PayoutRetained Earnings

BRUKER CORP

BIT:1BRKR (7/24/2025, 7:00:00 PM)

34.61

+34.61 (+Infinity%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners82.12%
Inst Owner ChangeN/A
Ins Owners26.98%
Ins Owner ChangeN/A
Market Cap5.24B
Analysts76.19
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.18
Dividend Growth(5Y)4.81%
DP38.44%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.87%
Min EPS beat(2)1.16%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)6.57%
EPS beat(8)6
Avg EPS beat(8)5.91%
EPS beat(12)9
Avg EPS beat(12)6.53%
EPS beat(16)12
Avg EPS beat(16)9.18%
Revenue beat(2)1
Avg Revenue beat(2)1.07%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.17%
Min Revenue beat(4)-1.45%
Max Revenue beat(4)2.76%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)1.07%
Revenue beat(16)11
Avg Revenue beat(16)1.46%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.8
Fwd PE 14.08
P/S 1.74
P/FCF 34.25
P/OCF 20.31
P/B 3.29
P/tB N/A
EV/EBITDA 13.68
EPS(TTM)2.06
EY5.95%
EPS(NY)2.46
Fwd EY7.1%
FCF(TTM)1.01
FCFY2.92%
OCF(TTM)1.7
OCFY4.92%
SpS19.94
BVpS10.52
TBVpS-3.57
PEG (NY)5.36
PEG (5Y)1.88
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 4.38%
ROCE 8.25%
ROIC 5.54%
ROICexc 5.77%
ROICexgc 12.9%
OM 10.99%
PM (TTM) 2.31%
GM 49.28%
FCFM 5.07%
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score3
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 12.11
Debt/EBITDA 3.59
Cap/Depr 60.1%
Cap/Sales 3.48%
Interest Coverage 250
Cash Conversion 50.93%
Profit Quality 219.35%
Current Ratio 1.57
Quick Ratio 0.72
Altman-Z 2.39
F-Score3
WACC7.6%
ROIC/WACC0.73
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.56%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-11.32%
EPS Next Y3.14%
EPS Next 2Y7.87%
EPS Next 3Y10.41%
EPS Next 5Y10.88%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%11.04%
Revenue Next Year4.82%
Revenue Next 2Y4.35%
Revenue Next 3Y4.78%
Revenue Next 5Y5.08%
EBIT growth 1Y-13.58%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year29.66%
EBIT Next 3Y16.46%
EBIT Next 5Y14.77%
FCF growth 1Y17.26%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y3.66%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%